CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D)
Abstract
Authors
BV Patel J Manjelievskaia SM Wang N Vaidya KW Mcdermott S Wall K Lavelle JE Pinsker D Brixner D Malone